Pharmaceutical industry – Page 5
-
Business
US trade regulator sues to block Amgen–Horizon merger
Federal Trade Commission has concerns that union will allow Amgen to stifle potential competition for Horizon’s drugs
-
Business
The diabetes drugs aiming to aid weight loss
Can peptide hormone mimics avoid the side effect pitfalls of previous weight loss treatments?
-
Business
US supreme court confirms Amgen’s cholesterol antibody patents invalid
Decision could mean patent descriptions need to be even more detailed, and hence expensive
-
Opinion
Regulators must follow their heads, not their hearts
The 2019 US approval of antibiotic Recarbrio seems not to have met the normally expected standards
-
Webinar
Building organisational consensus around the tools of digital chemistry
Learn how change agents at Johnson Matthey developed a coalition of support for data-driven science
-
Business
Deadly explosion and fire at US pharmaceutical plant
One worker killed and four hospitalised at Seqens in Newburyport
-
Opinion
Will a court overturn abortion drug’s approval?
Tangle between regulation and politics makes uncomfortable viewing from industry
-
Business
Merck & Co to buy immunology specialist Prometheus
$10.8 billion cash deal give Merck rights to late-stage candidate for two inflammatory bowel conditions
-
Business
Ghana and Nigeria approve Oxford malaria vaccine
Approval comes before final-stage clinical trials have been completed
-
Business
J&J proposes to pay nearly $9 billion to settle talc lawsuits
Company re-files for bankruptcy of a subsidiary in the hopes of resolving tens of thousands of claims its products caused cancer
-
Opinion
Meeting the tigers of the lab
Practical teaching strikes a balance between removing hazards and learning to respect them
-
Business
Pfizer to buy cancer biotech Seagen for $43 billion
Antibody-drug conjugate specialist will fill Pfizer’s cancer pipeline
-
Webinar
Robots in the lab – learn how automation can streamline your workflow
The future of lab automation is promising. Join us to find out answers to the most important questions, and to contribute your knowledge and experience to the discussion.
-
Opinion
Turning negative results into positives
Publishing unsuccessful experiments is more important than ever as we try to train machines in chemistry
-
Business
Contaminated cough syrups death toll passes 300 in four months
Deadly glycol contamination discovered in Uzbekistan, following cases in The Gambia and Indonesia
-
Business
Encoding creativity in drug discovery
Machine learning can complement and reinforce human intuition and experience
-
Opinion
The psychology of our future with AI
It’s time to accept that digitalisation is changing laboratory work, and embrace the opportunity
-
Business
Merck & Co identifies nitrosamine source in diabetes drugs
Investigation uncovers the cause of contamination in sitagliptin medicines, but the wider nitrosamine problem is ballooning
-
Business
Second Alzheimer’s antibody approved in the US
Biogen–Eisai’s lecanemab can slow disease progression a little, but at significant cost and risk of side effects